Successful thrombolytic therapy with recombinant tissue plasminogen activator in ischemic stroke after idarucizumab administration for reversal of dabigatran: a case report

Peer Review reports

Original Submission
5 Jun 2019	Submitted	Original manuscript
10 Nov 2019	Reviewed	Reviewer Report - Hürriyet Cetinok
17 Nov 2019	Reviewed	Reviewer Report - Melissa Ming Jie Chua
Resubmission - Version 2
	Submitted	Manuscript version 2
Publishing
26 Nov 2019	Editorially accepted
26 Dec 2019	Article published	10.1186/s13256-019-2326-y

Back to article page